RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.71B
1-Year Est. Return 43.68%
This Quarter Est. Return
1 Year Est. Return
+43.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.6B
AUM Growth
-$143M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$21.5M
2
+$21.2M
3
+$16.8M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12.6M
5
ACLX icon
Arcellx
ACLX
+$12.3M

Top Sells

1
+$105M
2
+$25.5M
3
+$23.9M
4
LEGN icon
Legend Biotech
LEGN
+$17.4M
5
UNH icon
UnitedHealth
UNH
+$15.6M

Sector Composition

1 Healthcare 98.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEN icon
76
Compugen
CGEN
$176M
$1.76M 0.11%
989,990
SION
77
Sionna Therapeutics
SION
$1.75B
$1.73M 0.11%
99,429
LUNG icon
78
Pulmonx
LUNG
$84.1M
$1.69M 0.11%
651,100
+147,400
NGNE icon
79
Neurogene
NGNE
$278M
$1.56M 0.1%
104,339
CATX icon
80
Perspective Therapeutics
CATX
$211M
$1.53M 0.1%
444,383
APLS icon
81
Apellis Pharmaceuticals
APLS
$3.45B
$1.46M 0.09%
84,300
+4,300
SRPT icon
82
Sarepta Therapeutics
SRPT
$2.5B
$1.17M 0.07%
68,600
-90,700
MRSN
83
DELISTED
Mersana Therapeutics
MRSN
$1.13M 0.07%
152,587
APLT icon
84
Applied Therapeutics
APLT
$14.5M
$646K 0.04%
2,075,991
+1,100
ADAP
85
DELISTED
Adaptimmune Therapeutics
ADAP
$595K 0.04%
2,483,468
KRRO icon
86
Korro Bio
KRRO
$89.5M
$446K 0.03%
35,719
CRL icon
87
Charles River Laboratories
CRL
$10.9B
$410K 0.03%
+2,700
ETNB
88
DELISTED
89bio
ETNB
$393K 0.02%
40,000
-804,441
PCVX icon
89
Vaxcyte
PCVX
$6.03B
$361K 0.02%
+11,100
NVAX icon
90
Novavax
NVAX
$1.18B
$340K 0.02%
53,900
-596,100
TLPH icon
91
Talphera
TLPH
$49.4M
$146K 0.01%
316,460
NUVB.WS icon
92
Nuvation Bio Inc Warrants
NUVB.WS
$61.2M
$36.2K ﹤0.01%
134,028
SPRB
93
Spruce Biosciences
SPRB
$85.6M
– –
-34,788
KMTS
94
Kestra Medical Technologies
KMTS
$1.43B
– –
-145,000
WRBY icon
95
Warby Parker
WRBY
$3.46B
– –
-835,000
VIGL
96
DELISTED
Vigil Neuroscience
VIGL
– –
-471,958
NVRO
97
DELISTED
NEVRO CORP.
NVRO
– –
-800,494
SGMT icon
98
Sagimet Biosciences
SGMT
$202M
– –
-787,808
BCRX icon
99
BioCryst Pharmaceuticals
BCRX
$1.56B
– –
-222,011
BEAM icon
100
Beam Therapeutics
BEAM
$2.8B
– –
-150,020
1 2 3
4
5